0001593968-20-001477.txt : 20200616 0001593968-20-001477.hdr.sgml : 20200616 20200616170049 ACCESSION NUMBER: 0001593968-20-001477 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200612 FILED AS OF DATE: 20200616 DATE AS OF CHANGE: 20200616 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Miller Andrew Craig CENTRAL INDEX KEY: 0001777760 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38958 FILM NUMBER: 20967117 MAIL ADDRESS: STREET 1: C/O KARUNA THERAPEUTICS, INC. STREET 2: 33 ARCH STREET, SUITE 3110 CITY: BOSTON STATE: MA ZIP: 02110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Karuna Therapeutics, Inc. CENTRAL INDEX KEY: 0001771917 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 270605902 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 33 ARCH STREET STREET 2: SUITE 3110 CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 857-449-2244 MAIL ADDRESS: STREET 1: 33 ARCH STREET STREET 2: SUITE 3110 CITY: BOSTON STATE: MA ZIP: 02110 4 1 primary_01.xml PRIMARY DOCUMENT X0306 4 2020-06-12 0001771917 Karuna Therapeutics, Inc. KRTX 0001777760 Miller Andrew Craig C/O KARUNA THERAPEUTICS, INC. 33 ARCH ST STE 3110 BOSTON MA 02110-1424 false true false false Chief Operating Officer Common Stock 2020-06-15 4 M false 33000 2.92 A 33000 D Common Stock 2020-06-12 4 M false 4968 7.27 A 37968 D Common Stock 2020-06-12 4 S false 4968 93.28 D 33000 D Common Stock 2020-06-15 4 M false 3571 7.27 A 36571 D Common Stock 2020-06-15 4 S false 3571 92.38 D 33000 D Common Stock 2020-06-12 4 M false 3365 9.2 A 36365 D Common Stock 2020-06-12 4 S false 3365 93.28 D 33000 D Common Stock 2020-06-15 4 M false 4762 9.2 A 37762 D Common Stock 2020-06-15 4 S false 4762 92.38 D 33000 D Common Stock 2020-06-16 4 M false 8334 9.2 A 41334 D Common Stock 2020-06-16 4 S false 8334 97.58 D 33000 D Option (right to buy) 2.92 2020-06-15 4 M false 33000 0 D 2016-07-18 2026-10-12 Common Stock 33000 109917 D Option (right to buy) 7.27 2020-06-12 4 M false 4968 0 D 2018-09-15 2028-08-09 Common Stock 4968 37828 D Option (right to buy) 7.27 2020-06-15 4 M false 3571 0 D 2018-09-15 2028-08-09 Common Stock 3571 34257 D Option (right to buy) 9.20 2020-06-12 4 M false 3365 0 D 2019-04-21 2029-03-21 Common Stock 3365 362159 D Option (right to buy) 9.20 2020-06-15 4 M false 4762 0 D 2019-04-21 2029-03-21 Common Stock 4762 357397 D Option (right to buy) 9.20 2020-06-16 4 M false 8334 0 D 2019-04-21 2029-03-21 Common Stock 8334 349063 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. /s/ Troy Ignelzi, Attorney-in-Fact 2020-06-16